What antibiotic should be used to treat a patient with a penicillin allergy who has tested positive for streptococcal (strep) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Selection for Streptococcal Infection with Penicillin Allergy

For patients with non-immediate (non-anaphylactic) penicillin allergy, use a first-generation cephalosporin such as cephalexin 500 mg twice daily for 10 days in adults or 20 mg/kg/dose twice daily for 10 days in children. 1, 2

For patients with immediate/anaphylactic penicillin allergy (history of anaphylaxis, angioedema, respiratory distress, or urticaria), use clindamycin 300 mg three times daily for 10 days in adults or 7 mg/kg/dose three times daily (maximum 300 mg/dose) for 10 days in children. 1, 2

Treatment Algorithm Based on Allergy Type

Step 1: Determine the Type of Penicillin Allergy

  • Immediate/anaphylactic reactions include anaphylaxis, angioedema, respiratory distress, or urticaria occurring within 1 hour of penicillin administration—these patients must avoid ALL beta-lactam antibiotics including cephalosporins due to up to 10% cross-reactivity risk. 3, 1, 2

  • Non-immediate reactions (delayed rash, mild gastrointestinal symptoms) carry only 0.1% cross-reactivity risk with first-generation cephalosporins, making them safe and preferred. 1, 2

Step 2: Select Appropriate Antibiotic

For Non-Immediate Penicillin Allergy (Preferred Options):

  • Cephalexin: 500 mg orally twice daily for 10 days (adults) or 20 mg/kg/dose twice daily for 10 days (children, maximum 500 mg/dose)—this has strong, high-quality evidence supporting efficacy and is the preferred first-line alternative. 1, 2

  • Cefadroxil: 1 gram orally once daily for 10 days (adults) or 30 mg/kg once daily for 10 days (children, maximum 1 gram)—equally effective with once-daily convenience. 1, 2

For Immediate/Anaphylactic Penicillin Allergy (Must Avoid All Beta-Lactams):

  • Clindamycin (PREFERRED): 300 mg orally three times daily for 10 days (adults) or 7 mg/kg/dose three times daily for 10 days (children, maximum 300 mg/dose)—this has only ~1% resistance among Group A Streptococcus in the United States and demonstrates superior eradication rates even in chronic carriers. 1, 2

  • Azithromycin: 500 mg orally once daily for 5 days (adults) or 12 mg/kg once daily for 5 days (children, maximum 500 mg)—this is FDA-approved for streptococcal pharyngitis and requires only 5 days due to prolonged tissue half-life, but has 5-8% macrolide resistance in the United States. 1, 2, 4

  • Clarithromycin: 250 mg orally twice daily for 10 days (adults) or 7.5 mg/kg/dose twice daily for 10 days (children, maximum 250 mg/dose)—similar efficacy to azithromycin but requires full 10-day course. 1, 2

Critical Treatment Duration Requirements

  • All antibiotics except azithromycin require a full 10-day course to achieve maximal pharyngeal eradication of Group A Streptococcus and prevent acute rheumatic fever—shortening the course by even a few days results in appreciable increases in treatment failure rates. 1, 2

  • Azithromycin is the only exception, requiring only 5 days due to its unique pharmacokinetics and prolonged tissue half-life. 1, 2, 4

Important Resistance Considerations

  • Clindamycin resistance remains very low at approximately 1% among Group A Streptococcus isolates in the United States, making it the most reliable non-beta-lactam option. 1, 2

  • Macrolide resistance (azithromycin, clarithromycin, erythromycin) is approximately 5-8% in the United States but varies geographically—some areas experience much higher rates, making clindamycin preferred when beta-lactams cannot be used. 1, 2

  • First-generation cephalosporins have essentially 0% resistance and strong, high-quality evidence for efficacy in non-anaphylactic penicillin-allergic patients. 1, 2

Common Pitfalls to Avoid

  • Do NOT use cephalosporins in patients with immediate hypersensitivity reactions (anaphylaxis, angioedema, respiratory distress, urticaria within 1 hour)—the 10% cross-reactivity risk makes this unsafe. 1, 2

  • Do NOT assume all penicillin-allergic patients cannot receive cephalosporins—only those with immediate/anaphylactic reactions should avoid them; patients with delayed, non-severe reactions have only 0.1% cross-reactivity risk. 1, 2

  • Do NOT prescribe shorter courses than recommended (except azithromycin's 5-day regimen)—this dramatically increases treatment failure and acute rheumatic fever risk. 1, 2

  • Do NOT use broad-spectrum cephalosporins (cefdinir, cefixime, cefpodoxime) when narrow-spectrum first-generation agents (cephalexin, cefadroxil) are appropriate—they are more expensive and more likely to select for antibiotic-resistant flora. 1

  • Do NOT ignore local macrolide resistance patterns—in areas with high macrolide resistance, clindamycin or first-generation cephalosporins are strongly preferred over azithromycin or clarithromycin. 1, 2

Special Considerations for Group B Streptococcus (Pregnant Women)

  • For pregnant women requiring intrapartum antibiotic prophylaxis with non-immediate penicillin allergy: cefazolin 2 grams IV initial dose, then 1 gram IV every 8 hours until delivery. 3, 2

  • For pregnant women with immediate/anaphylactic penicillin allergy and susceptible isolate: clindamycin 900 mg IV every 8 hours until delivery (requires susceptibility testing). 3, 2

References

Guideline

Treatment of Streptococcal Infections in Patients with Penicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Treatment for Streptococcal Infections in Penicillin-Allergic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.